Improvement in the neutron beam collimation for application in boron neutron capture therapy of the head and neck region.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 08 2022
Historique:
received: 15 04 2022
accepted: 03 08 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 17 8 2022
Statut: epublish

Résumé

In June 2020, the Japanese government approved boron neutron capture therapy for the treatment of head and neck cancer. The treatment is usually performed in a single fraction, with the neutron irradiation time being approximately 30-60 min. As neutrons scatter in air and loses its intensity, it is preferable to bring the patient as close to the beam port as possible to shorten the irradiation time. However, this can be a challenge, especially for patients with head and neck cancer, as the shoulders are an obstacle to a clean positioning. In this study, a novel neutron collimation system for an accelerator based neutron source was designed to allow for a more comfortable treatment, without compromising the irradiation time. Experimental measurements confirmed the simulation results and showed the new collimator can reduce the irradiation time by approximately 60% (under the same condition where the distance between the source and the patient surface was kept the same). The dose delivered to the surrounding healthy tissue was reduced with the new collimator, showing a 25% decrease in the D

Identifiants

pubmed: 35962034
doi: 10.1038/s41598-022-17974-7
pii: 10.1038/s41598-022-17974-7
pmc: PMC9374716
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13778

Informations de copyright

© 2022. The Author(s).

Références

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):404-410
pubmed: 26797537
Appl Radiat Isot. 2020 Dec;166:109222
pubmed: 32755755
Appl Radiat Isot. 2011 Dec;69(12):1642-5
pubmed: 21463945
Radiother Oncol. 2021 Feb;155:182-187
pubmed: 33186684
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e67-75
pubmed: 21300462
Radiat Res. 2012 Dec;178(6):609-21
pubmed: 23148506
Australas Phys Eng Sci Med. 2003 Sep;26(3):97-103
pubmed: 14626847
Radiat Res. 1998 Feb;149(2):163-70
pubmed: 9457896
Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1121-9
pubmed: 8262837
Appl Radiat Isot. 2004 Nov;61(5):1069-73
pubmed: 15308194
Radiat Oncol. 2021 Dec 24;16(1):243
pubmed: 34952608
Radiat Res. 1995 Dec;144(3):310-7
pubmed: 7494875
Phys Med Biol. 2004 Aug 7;49(15):3353-65
pubmed: 15379018
Int J Clin Oncol. 2014;19(3):437-44
pubmed: 23797210

Auteurs

Naonori Hu (N)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan. naonori.ko@ompu.ac.jp.
Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan. naonori.ko@ompu.ac.jp.

Hiroki Tanaka (H)

Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan.

Ryo Kakino (R)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Syuushi Yoshikawa (S)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Mamoru Miyao (M)

Central Department of Radiology, Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan.

Kazuhiko Akita (K)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Teruhito Aihara (T)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Keiji Nihei (K)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Department of Radiation Oncology, Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan.

Koji Ono (K)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH